Fujimak Corporation
Notice Regarding Recording of Extraordinary Income from Sale of Marketable Securities
The Company will record extraordinary income of 874 million yen from the sale of marketable securities. The sale occurred in September and was aimed at improving capital efficiency and securing funds for growth investments. The extraordinary income is scheduled to be recorded in the cumulative third quarter period of the fiscal year ending December 2026. Full-year forecasts are currently under review and may be revised.
Key Figures
- Gain on Sale of Marketable Securities: 874 million yen
- Sale Period: September 2026
- Timing of Full-Year Forecast Revision: Currently under review
AI要約
Impact on Results and Extraordinary Income
The Company sold part of its listed securities holdings and will record a gain on sale of marketable securities of 874 million yen as extraordinary income. This extraordinary income is scheduled to be recorded in the cumulative third quarter period of the fiscal year ending December 2026, and the proceeds, while improving capital efficiency, will be allocated to future growth investments. The disposal covered five issues, and the sale period is stated as September 2026.
Outlook and Notes
The consolidated full-year earnings forecast is currently under review, taking other factors into account, and if a revision to the forecast becomes necessary it will be disclosed promptly. Exchange rate information is provided separately, and the current impact is unknown.
Fujimak Corporation
Company overview · Stock price · Financial data · All IR
